share_log

60 Degrees Pharmaceuticals Shares Are Trading Higher After the Company Announced Ethics Approval of an Open Label, Expanded Access Study of the ARAKODA Regimen of Tafenoquine in Combination With Standard of Care Regimens in Immunosuppressed Patients...

Benzinga ·  Jul 9 08:13

60 Degrees Pharmaceuticals Shares Are Trading Higher After the Company Announced Ethics Approval of an Open Label, Expanded Access Study of the ARAKODA Regimen of Tafenoquine in Combination With Standard of Care Regimens in Immunosuppressed Patients With Persistent/relapsing Babesiosis

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment